SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001711279-23-000073
Filing Date
2023-11-06
Accepted
2023-11-06 07:08:53
Documents
66
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q krys-20230930.htm   iXBRL 10-Q 1286251
2 EX-31.1 krys-20230930ex311.htm EX-31.1 10686
3 EX-31.2 krys-20230930ex312.htm EX-31.2 10649
4 EX-32.1 krys-20230930ex321.htm EX-32.1 11170
  Complete submission text file 0001711279-23-000073.txt   6524392

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT krys-20230930.xsd EX-101.SCH 40520
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT krys-20230930_cal.xml EX-101.CAL 58629
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT krys-20230930_def.xml EX-101.DEF 158640
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT krys-20230930_lab.xml EX-101.LAB 594793
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT krys-20230930_pre.xml EX-101.PRE 372100
60 EXTRACTED XBRL INSTANCE DOCUMENT krys-20230930_htm.xml XML 1018971
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38210 | Film No.: 231378091
SIC: 2836 Biological Products, (No Diagnostic Substances)